Cargando…
A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease
Early research into Alzheimer's disease launched the cholinergic hypothesis, based on the correlation between central cholinergic deficiency and clinical measures of cognitive decline. This was epitomized in therapeutic strategies employing a variety of procholinergic agents, of which only the...
Autor principal: | S. Schneider, Lon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181592/ https://www.ncbi.nlm.nih.gov/pubmed/22033801 |
Ejemplares similares
-
Treatment of depression in late life
por: Schneider, Lon S.
Publicado: (1999) -
Treatment of cognitive impairment in Alzheimer's disease
por: Burns, Alistair
Publicado: (2003) -
Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011) -
Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000) -
Drug treatment of Parkinson's disease
por: Korczyn, Amos D.
Publicado: (2004)